BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 1426820)

  • 1. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.
    Colombel JF; Reumaux D; Duthilleul P; Noël LH; Gower-Rousseau C; Paris JC; Cortot A
    Gastroenterol Clin Biol; 1992; 16(8-9):656-60. PubMed ID: 1426820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
    Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
    Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ
    Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antineutrophil cytoplasmic antibodies in chronic inflammatory bowel diseases].
    Schlenker T; Apenberg S; Raedsch R; Andrassy K; Plachky J; Kommerell B
    Dtsch Med Wochenschr; 1992 Sep; 117(39):1463-8. PubMed ID: 1396127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
    Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
    Papo M; Quer JC; Pastor RM; García-Pardo G; Olona M; Prats E; Mirapeix E; Rodríguez R; Richart C
    Med Clin (Barc); 1998 Jan; 110(1):11-5. PubMed ID: 9527980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease.
    Cabral VL; Miszputen SJ; Catapani WR
    Hepatogastroenterology; 2003; 50(50):412-5. PubMed ID: 12749235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
    Kull K; Salupere R; Uibo R; Ots M; Salupere V
    Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease.
    Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C
    Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.
    Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH
    Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
    Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: diagnostic tool or research procedure?
    Andreani ML; Frascà G; Brusco G; Borgnino L; Biagi F; Gasbarrini G; Corazza GR
    Ann Ital Med Int; 1996; 11(4):254-7. PubMed ID: 9050283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease].
    García-Herola A; Nos P; Hoyos M; Hinojosa J; Molés JR; Pascual S; Bustamante M; Sánchez Cuenca JM; Carmona E; Ponce J; Berenguer J
    Gastroenterol Hepatol; 1998 Apr; 21(4):169-73. PubMed ID: 9633176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory diseases of the digestive tract].
    Lamproye A; Belaiche J; Louis E; Salmon J; Mahieu P
    Acta Gastroenterol Belg; 1994; 57(2):171-6. PubMed ID: 8053303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
    Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
    Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.